METABOLIC-ASSOCIATED FATTY LIVER DISEASE
Clinical trials for METABOLIC-ASSOCIATED FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC-ASSOCIATED FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC-ASSOCIATED FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut drug shows promise against fatty liver in small trial
Disease control Recruiting nowThis early-stage study is testing whether the antibiotic rifaximin can safely reduce fat buildup in the liver for people with metabolic-associated fatty liver disease (MAFLD). About 40 adults will take rifaximin pills three times a day for up to 48 weeks while following a healthy…
Matched conditions: METABOLIC-ASSOCIATED FATTY LIVER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
New MRI tech could spare fatty liver patients painful biopsies
Knowledge-focused Recruiting nowThis study explores whether a new type of MRI can accurately measure fat and metabolism in the liver without needing a needle biopsy. Researchers will scan 500 people with metabolic fatty liver disease and compare the results to standard tests. If successful, this could lead to a…
Matched conditions: METABOLIC-ASSOCIATED FATTY LIVER DISEASE
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 05:37 UTC
-
Scientists probe hidden link between diabetes, fatty liver, and glucagon resistance
Knowledge-focused Recruiting nowThis study looks at how the hormone glucagon works in people with type 2 diabetes, especially those who also have fatty liver disease. Researchers want to know if glucagon resistance makes liver and heart problems worse. Participants will have scans, blood tests, and fat biopsies…
Matched conditions: METABOLIC-ASSOCIATED FATTY LIVER DISEASE
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 17, 2026 05:30 UTC